Skip to main content

Table 16 PD patient distribution, by treatment for EPS and dialysis modality

From: Annual peritoneal dialysis report 2014, the peritoneal dialysis registry

Treatment for EPS

EPS (−)

EPS (+)

Subtotal

Unspecified

No information available

Total

Surgery (+) steroids (+)

Surgery (+) steroids (−)

Surgery (−) steroids (+)

Surgery (−) steroids (−)

In-center HD (%)

5051 (91.2)

376 (6.8)

12 (0.2)

56 (1.0)

46 (0.8)

5541 (100.0)

198

730

6469

HDF (%)

1250 (90.5)

104 (7.5)

3 (0.2)

9 (0.7)

15 (1.1)

1381 (100.0)

35

161

1577

Hemofiltration (%)

1 (100.0)

1 (100.0)

1

Hemoadsorption (%)

46 (79.3)

8 (13.8)

1 (1.7)

3 (5.2)

58 (100.0)

4

3

65

Home HD (%)

72 (98.6)

1 (1.4)

73 (100.0)

4

77

PD (%)

5769 (99.3)

36 (0.6)

3 (0.1)

3 (0.1)

5811 (100.0)

67

3063

8941

Subtotal (%)

12,189 (94.7)

525 (4.1)

16 (0.1)

68 (0.5)

67 (0.5)

12,865 (100.0)

304

3961

17,130

No information available (%)

Total (%)

12,189 (94.7)

525 (4.2)

16 (0.2)

68 (0.6)

67 (0.4)

12,865 (100.0)

304

3961

17,130

  1. These data were obtained from the patients on PD and the patients with past PD history currently on another dialysis modality
  2. EPS encapsulating peritoneal sclerosis